Document is current
Any future updates will be listed below
-
Authors
Gagne, Matthew
Flynn, Barbara J.
Andrew, Shayne F. http://orcid.org/0000-0001-7226-7757
Marquez, Josue
Flebbe, Dillon R.
Mychalowych, Anna
Lamb, Evan
Davis-Gardner, Meredith E. http://orcid.org/0000-0002-6133-3613
Burnett, Matthew R.
Serebryannyy, Leonid A.
Lin, Bob C.
Ziff, Zohar E.
Maule, Erin
Carroll, Robin
Naisan, Mursal
Jethmalani, Yogita http://orcid.org/0000-0003-3422-8356
Pessaint, Laurent
Todd, John-Paul M.
Doria-Rose, Nicole A. http://orcid.org/0000-0002-5731-3054
Case, James Brett http://orcid.org/0000-0001-7331-5511
Dmitriev, Igor P. http://orcid.org/0000-0001-9206-1975
Kashentseva, Elena A.
Ying, Baoling
Dodson, Alan
Kouneski, Katelyn
O’Dell, Sijy
Wali, Bushra
Ellis, Madison http://orcid.org/0000-0002-0325-5477
Godbole, Sucheta
Laboune, Farida
Henry, Amy R.
Teng, I-Ting
Wang, Danyi
Wang, Lingshu
Zhou, Qiong
Zouantchangadou, Serge
Van Ry, Alex http://orcid.org/0000-0002-1240-9044
Lewis, Mark G. http://orcid.org/0000-0001-7852-0135
Andersen, Hanne http://orcid.org/0000-0003-1103-9608
Kwong, Peter D.
Curiel, David T. http://orcid.org/0000-0003-3802-6014
Roederer, Mario
Nason, Martha C.
Foulds, Kathryn E.
Suthar, Mehul S. http://orcid.org/0000-0002-2686-8380
Diamond, Michael S. http://orcid.org/0000-0002-8791-3165
Douek, Daniel C. http://orcid.org/0000-0001-5575-8634
Seder, Robert A. http://orcid.org/0000-0003-3133-0849
- License Information
-
More Information
Article History
Received: 15 January 2024
Accepted: 6 August 2024
First Online: 3 September 2024
Competing interests
: M.S.D. is a consultant for Inbios, Vir Biotechnology, Ocugen, Topspin Therapeutics, Merck, GSK and Moderna. The laboratory of M.S.D. has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Emergent BioSolutions and Moderna. D.T.C. is a consultant for Ocugen, Circero, Asgard, Accession and Tome Biosciences. M.S.D., D.T.C. and I.P.D. are inventors of the ChAd-SARS-CoV-2 technology, which Washington University has licensed to Bharat Biotech and Ocugen for commercial development. M.S.S. serves on the scientific board of advisors for Moderna and Ocugen. A.R.H., P.D.K., M.R. and D.C.D. are inventors on US Patent Application 63/147,419 entitled ‘Antibodies targeting the spike protein of coronaviruses’. L.P., A.D., K.K., S.Z., A.V.R., M.G.L. and H.A. are employees of Bioqual. The other authors declare no competing interests.
